[OS13] Bacteria 2 (Respiratory) | APVS2025

Advanced Search

Session Details

Oral Session

[OS13]Bacteria 2 (Respiratory)

Wed. Nov 12, 2025 10:05 AM - 11:05 AM JST
Wed. Nov 12, 2025 1:05 AM - 2:05 AM UTC

Room A(3F)

10:05 AM - 10:20 AM JST(1:05 AM - 1:20 AM UTC)

[OS13-1]Immunization of pigs with Actinobacillus pleuropneumonia live attenuated (gene-deleted) vaccine HB04M intramuscularly or intranasally exhibits remarkably rapid protection against heterologous strain’s challenge

*Song Qi¹, Qi yun He¹, Wei cheng Bei¹ (1. National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University (China))

10:20 AM - 10:35 AM JST(1:20 AM - 1:35 AM UTC)

[OS13-2]Efficacy of CAV1-Fc Fusion Protein in Protecting Mice from ApxI Toxin-Induced Damage

*Mengdi Zhang¹, Yaofang Hu¹, Qigai He¹, Wentao Li¹ (1. National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University (China))

10:35 AM - 10:50 AM JST(1:35 AM - 1:50 AM UTC)

[OS13-3]Comparative whole geneomic analysis of recent Korean isolates of Actinobacillus pleuropneumoniae

*Eun-Seo LEE¹, Su Min KYUNG¹, Jun Ho LEE¹, Xi Rui Xiang¹, HAN SANG YOO¹ (1. College of Veterinary Medicine, Seoul National University (Korea))

10:50 AM - 11:05 AM JST(1:50 AM - 2:05 AM UTC)

[OS13-4]Economic loss due to Actinobacillus pleuropneumonia demonstrated by Ceva Lung Program

Michael Groes Christiansen¹, Charlotte Sonne Christensen², Michael Albin², *PREBEN MORTENSEN³ (1. SEGES Innovation (Denmark), 2. Ceva Animal Health A/S (Denmark), 3. Ceva Corporate Swine (France))

Back to Category List